侵袭性肺曲霉菌感染实验诊断新进展

doi:10.3969/j.issn.1673-8640.2021.04.022

摘要/Abstract

摘要：

从病原学（涂片镜检、培养）、组织病理学、分子生物学和13种曲霉菌生物标志物及联合检测等方面探讨不同侵袭性肺曲霉菌感染（IPAI）检测方法的诊断效能。组织病理学阳性率为87.5%;涂片镜检敏感性为87.7%、特异性为72.1%;培养阳性率<61%,其中痰液、支气管肺胞灌洗液（BALF）、血液样本培养阳性率分别为12%、40%~50%、<5%;聚合酶链反应（PCR）的检测敏感性和特异性分别为50%~100%和75%~89%;生物标志物敏感性为61%~100%、特异性为77%~95%;联合检测敏感性为73%~94%、特异性为0.81%~99.4%。不同检测方法的敏感性和特异性差异较大。生物标志物检测具有快速、敏感、特异的特点;联合检测诊断意义较大。

关键词: 侵袭性肺曲霉菌感染, 曲霉菌, 检测方法, 敏感性, 特异性, 生物标志物

Abstract:

The diagnostic performance of invasive pulmonary Aspergillus infection（IPAI） determinations were evaluated in terms of etiology（smear microscopy,culture）,immunohistochemistry,molecular biology,13 kinds biomarkers of Aspergillus and combined determination. The positive rate of immunohistochemistry was 87.5%. The sensitivity of smear microscopy was 87.7%,and the specificity was 72.1%. The positive rate of culture was <61%. Among these specimens,sputum accounted for 12%,bronchoalveolar lavage fluid（BALF） accounted for 40%-50%,and blood accounted for <5%. The sensitivity and the specificity of molecular biology were 50%-100% and 75%-89%,respectively. The sensitivity of biomarkers was 61%-100%,and the specificity was 77%-95%. The sensitivity of combined determination was 73%-94%,and the specificity was 0.81%-99.4%. The sensitivities and specificities of these technologies are different,the determations of biomarkers have the characteristics of rapidity,high sensitivity and high specificity,and the combined determination is of great significance.

Key words: Invasive pulmonary Aspergillus infection, Aspergillus, Determination, Sensitivity, Specificity, Biomarker

中图分类号:

R446.1

高东田, 刘利华, 申爱华, 孙寅. 侵袭性肺曲霉菌感染实验诊断新进展[J]. 检验医学, 2021, 36(4): 453-461.

GAO Dongtian, LIU Lihua, SHEN Aihua, SUN Yin. Progress of IPAI experimental diagnosis[J]. Laboratory Medicine, 2021, 36(4): 453-461.

参考文献 42

[1]	高东田, 申爱华. GM试验和G试验对侵袭性肺部真菌感染的诊断价值及临床疗效评价[J]. 检验医学, 2018,33(1):44-49.
[2]	马蕾, 李挺, 李若瑜, 等. EnVision免疫组织化学二步法在诊断深部真菌感染上的应用[J]. 临床皮肤科杂志, 2002,31(8):501-503.
[3]	WHITE P L, WIEDERHOLD N P, LOCFFLER J, et al. Comparison of nonculture blood-based tests for diagnosing invasive aspergillosis in an animal model[J]. J Clin Microbiol, 2016,54(4):960-966.
[4]	刘昶, 谢苗荣. 肺部真菌感染实验室早期诊断方式研究[J]. 临床和实验医学杂志, 2016,15(8):821-823.
[5]	司淑一. 侵袭性肺曲霉菌病诊断进展[J]. 中国临床医生杂志, 2016,44(7):20-23.
[6]	PAIVA J A, MERGULHÃO P, PEREZRA J M. Aspergillus and other respiratory fungal infections in the ICU:diagnosis and management[J]. Curr Opin Infect Dis, 2018,31(2):187-193. DOI URL PMID
[7]	WITTWER C T, RIRIE K M, ANDREW R V, et al. Gundry RA and Balis U[J]. Biotechniques, 1997,22:178-183.
[8]	朱利平, 翁心华. 侵袭性真菌感染的分子诊断在造血干细胞移植及血液恶性肿瘤患者中的应用[J]. 诊断学理论与实践, 2010,9(1):14-18.
[9]	WANG Y, CHEN L, LIU X, et al. Detection of Aspergillus fumigatus pulmonary fungal infections in mice with(99m)Tc-labeled MORF oligomers targeting ribosomal RNA[J]. Nucl Med Biol, 2013,40(1) : 89-96. DOI URL PMID
[10]	夏云, 杜丽, 何云燕. 侵袭性曲霉病实验室诊断的现状和展望[J]. 中华检验医学杂志, 2018,41(1):9-12.
[11]	ARVANITIS M, MYLONAKIS E. Digagnosis of invasive aspergillosis:recent gevelopments and ongoing challenges[J]. Eur J Clin Invest, 2015,45(6):646-652. DOI URL PMID
[12]	宋一祎, 李华茵. 侵袭性肺曲霉病实验室检测方法的研究进展[J]. 中国临床医学, 2018,25(5):804-809.
[13]	中国医药教育协会感染疾病专业委员会. 感染相关生物标志物临床意义解读专家共识[J]. 中华结核和呼吸杂志, 2017,40(4):243-257.
[14]	REISCHIES F M J, RAGGAM R B, PRATTES J, et al. Urine galactomannan-to-creatinine ratio for detection of invasive aspergillosis in patients with hematological malignancies[J]. J Clin Microbiol, 2016,54(3):771-774. DOI URL PMID
[15]	DUFRESNE S F, DATTA K, LI X, et al. Detection of urinary excreted fungal galactomannan like antigens for diagnosis of invasive aspergillosis[J]. PLoS One, 2012,7(8):e42736. DOI URL PMID
[16]	刘书娟, 樊慧珍, 于华鹏, 等. 半乳甘露聚糖在侵袭性肺曲霉感染大鼠模型诊断中的意义[J]. 山东医药, 2010,50(20):40-42.
[17]	王莹. 儿童侵袭性曲霉病诊治进展[J]. 中华实用儿科临床杂志, 2017,32(6 ): 412-416.
[18]	PATTERSON T F, THOMPSON G R 3rd, DENNING D W, et al. Practice guidelines for the diagnosis and management of aspergillosis：2016 update by the infections disenses society of America[J]. Clin Infect Dis, 2016,63(4):el-e60. DOI URL PMID
[19]	GARLANDA C, JAILLON S, DONI A, et al. PTX3,a humoral pattern recognition molecule at the interface between microbe and matrix recognition[J]. Curr Opin Immunol, 2016,38:39-44. DOI URL PMID
[20]	ORASCH T, PRATTES J, FASERL K, et al. Bronchoalveolar lavage triacetylfusarinine C(TAFC) delermination for diagnosis of invasive pulmonary aspergillosis in patient with hematological malignancies[J]. J Infect, 2017,75(4):370-373. DOI URL PMID
[21]	VIDAL-GARCÍA M, DOMINGO M P, DE RUEDA B, et al. Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis[J]. Appl Microbiol Biotechnol, 2016,100(5):2327-2334. DOI URL PMID
[22]	AGARWAL R, CHAKRABARTI A. Allergic bronchopulmonary aspergillosis in asthma:epidemiological,clinical and therapeutic issues[J]. Future Microbiol, 2013,8(11):1463-1474. DOI URL PMID
[23]	CHAMBERS S T, SYHRE M, MURDOCH D R, et al. Dectection of 2-pentylfuran in the breath of patients with Aspergillus fumigates[J]. Med Mycol, 2009,47(5):468-476. URL PMID
[24]	曾秋琼, 王逢源, 张征, 等. 曲霉菌诊疗进展[J]. 皮肤科学通报, 2017,34(5):594-603.
[25]	HEINZ W J, BUCHHEIDT D, ULLMANN A J. Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections[J]. Mycoses, 2016,59(8):480-493. DOI URL PMID
[26]	杨燕, 胡华. 非培养检测技术在曲霉菌感染中的临床应用进展[J]. 临床肺科杂志, 2012,17(12):2259-2260.
[27]	HELDT S, EIGL S, PRATTES J, et al. Levels of interleukin(IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis[J]. Mycoses, 2017,60(12):818-825. DOI URL PMID
[28]	胡晓艳, 姜梁. 老年人血清INF-α、IL-1β、IL-8、IL-6含量与患肺曲霉病的相关性[J]. 中国老年学杂志, 2013,33(4):940-941.
[29]	AERNI H R, CORNETT D S, CAPRIOLI R M. Automated acoustic matrix deposition for MALDI sample preparation[J]. Anal Chem, 2006,78(3):827-834. DOI URL PMID
[30]	MARTY F M, OSTROSKY-ZEICHNER L, CORNELY O A, et al. Lsavuconazole treatment for mucormycosis:a single-arm open-label trial and case-control analysis[J]. The Lancet Infect Dis, 2016,16(7):828-837. DOI URL PMID
[31]	张福军, 陈涌泉. 核糖体蛋白保存条件对基质辅助激光解吸电离飞行时间质谱技术鉴定曲霉菌的影响[J]. 国际医药卫生导报, 2018,24(8):1161-1163.
[32]	THORNTON C R. Development of an immuno-chromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis[J]. Clin VACCINE Immunol, 2008,15(7):1095-1105. DOI URL PMID
[33]	HOENIGL M, PRATTES J, SPIESS B, et al. Performance of galactomannan,beta-D-glucan,Aspergillus lateral-flow device,conventional culture,and PCR tests with bronchoalveolar lavage fluid for invasive pulmonary aspergillosis[J]. J Clin Microbiol, 2014,52(6):2039-2045. URL PMID
[34]	PAN Z, FU M, ZHANG J, et al. Diagnostic accuracy of a novel lateral-flow device in invasive dspergillosis:a meta-analysis[J]. J Med Microbiol, 2015,64(7):702-707. DOI URL PMID
[35]	EIGL S, PRATTES J, LACKNER M, et al. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients[J]. Crit Care, 2015,19(1):178.
[36]	于书娴、崔学范马婷, 等. G试验和GM试验对侵袭性真菌病诊断价值的Meta分析[J]. 中华肺部疾病杂志(电子版), 2016,9(2):164-170.
[37]	刘利华, 刘元元, 高东田, 等. 痰培养联合曲霉血清学GM试验对诊断侵袭性曲霉菌感染的临床价值研究[J]. 中国呼吸与危重监护杂志, 2016,15(6):607-609.
[38]	ORASCH T, PRATTES J, FASERL K, et al. Bronchoalveolar lavage triacetylfusarinine C(TAFC) delermination for diagnosis of invasive pulmonary aspergillosis in patient with hematological malignancies[J]. J Infect, 2017,75(4):370-373. DOI URL PMID
[39]	应华娟, 王华英, 陈晓飞, 等. 血清及肺胞灌洗液GM试验对侵袭性肺曲霉早期诊断价值的比较[J]. 现代实用医学, 2017,29(1):7-10.
[40]	邓劲, 吴思颖, 康梅. 血清及肺泡灌洗液半乳甘露聚糖检测对非粒细胞缺乏患者侵袭性曲霉菌感染的诊断价值[J]. 检验医学与临床, 2017,14(12):1762-1764.
[41]	BOCH T, SPIESS B, COMELY O A, et al. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan,1,3-β-D-glucan,Aspergillus PCR,multifungal DNA-microarray,and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples:result of a prospective multicentre study[J]. Clin Microbiol Infect, 2016,22(10):862-868. DOI URL PMID
[42]	HOENIGL M, PRATTES J, APIESS B, et al. Performance of galactomannan,beta-d-glucan,Aspergillus lateral-flow device,conventional culture,and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis[J]. J Clin Microbiol, 2014,52(6):2039-2045. DOI URL PMID